Blackstone Life Sciences Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
15
- Investments
-
118
- Portfolio
-
19
- Exits
-
72
Blackstone Life Sciences General Information
Description
Founded in 2005, Blackstone Life Sciences is a private equity firm based in Cambridge, Massachusetts. The firm seeks to invest in companies operating in the life science, pharmaceutical, medical device research, medical technology, and healthcare sectors.
Contact Information
Website
www.clarusfunds.com
Formerly Known As
Clarus Ventures, LLC, Clarus, Clarus-Ventures, Klarus Ventures, ClarusVentures, Clarus Venture, Clarus Ventures, Limited Liability Company, Clarus Ventures
Year Founded
2005
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
PE/Buyout
Other Investor Types
Venture Capital
Primary Office
- 101 Main Street
- Suite 1210
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Blackstone Life Sciences Investments & Acquisitions (118)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 0000000 | 12-Nov-2021 | 0000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | 00000000 000000000 00.0 |
| 00000000 000000000 | 30-Jul-2021 | 00000 000000 | 00000 | Biotechnology | Generating Revenue | 0000000 00000000000 |
| 00000000 | 04-Jan-2021 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | |
| 00000 00000000000 | 19-Nov-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 000000 000000 00.0 |
| Talaris Therapeutics | 30-Sep-2020 | Later Stage VC | 00000 | Biotechnology | Clinical Trials - Phase 3 | 00000 0000000 00 |
Blackstone Life Sciences Exits (72)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 00000 00000000000 | 09-Jul-2021 | 000 | 00000 |
| 00000000 | 01-Jul-2021 | 000000000 00000000 | |
| 000000 | 14-May-2021 | 000000 0000000000 | 000.00 |
| 0000000 0000000000 | 07-May-2021 | 000 | 00000 |
| SFJ Pharmaceuticals | 01-Mar-2021 | Secondary Transaction - Private |
Blackstone Life Sciences Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Blackstone Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Blackstone Life Sciences Team (44)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| M. Craig Shepherd | Senior Managing Director & Investment Committee Member | Cambridge, MA | |||
| Nicholas Simon | Senior Managing Director & Investment Committee Member | 0 | 0 | 0 | Cambridge, MA |
| Robert Liptak | Senior Managing Director & Investment Committee Member | 0 | 0 | Cambridge, MA | |
| Kurt Wheeler | Co-Founder, Investment Committee Member & Senior Managing Director | 00 | 0 | 0 | Cambridge, MA |
| Kiran Reddy MD | Senior Managing Director | 0 | 0 | Cambridge, MA |